Mon-Fri 9:00-18:00 CET+39 095 7211344info@vitasanlabs.com

Family · Pharmaceutical analytical standards

Quetiapine

An atypical antipsychotic of the dibenzothiazepine family, developed in 1985 and approved in the United States in 1997; it is used for schizophrenia and bipolar disorder. This family brings together the active ingredient, pharmacopoeial impurities, metabolites, labelled standards, nitrosamines and other impurities.

Did you know?In the body it is partly converted into norquetiapine, an active metabolite that also blocks the noradrenaline transporter, as some antidepressants do.

QuetiapineGo to the active ingredient →
QuetiapineActive ingredientQuetiapineCat. No. P-Q003-001CAS 111974-69-7

EDQM standards 2

The official European Pharmacopoeia standards for this family.

Need a molecule you cannot find?

Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.